Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

PHASE2UnknownINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Tuberculosis Infection
Interventions
BIOLOGICAL

To confirm the potency of Aplisol formulated with newly produced Tuberculin PPD compared to PPD-S2 standard.

Comparison of different dosages of Aplisol PPD relative to reference standard PPD-S2.

BIOLOGICAL

Reactivity of Aplisol compared to reference standard PPD-S2.

Reference standard PPD-S2 formulated to contain different dose concentrations.

Trial Locations (1)

75708

RECRUITING

The University of Texas Health Science Center at Tyler, Tyler

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

JHP Pharmaceuticals LLC

INDUSTRY